Skip to main content
. 2017 Sep 14;12(9):e0184094. doi: 10.1371/journal.pone.0184094

Fig 4. Comparison between circulating miR-200b expression levels and clinic-pathological features.

Fig 4

The superior line represents the miR200b expression according to the: a. presence or absence of metastasis; b. unilateral or bilateral tumors; c. Low or high PSA levels; and, d. Gleason score ≤ 6 or ≥ 7. e-h. The ROC (Receiver Operating Characteristic) curve analysis for each histopathological feature. PCa = prostate cancer; mPCa = metastatic prostate cancer; AUC = area under the curve. *Statistically significant (Student’s t-test P < 0.05).